Charles Schwab Investment Management Inc Optimize Rx Corp Transaction History

Charles Schwab Investment Management Inc

  • $601 Billion
  • Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Optimize Rx Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 75,127 shares of OPRX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75,127
Previous 51,512 45.84%
Holding current value
$1.14 Million
Previous $695,000 121.58%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$12.48 - $20.51 $294,715 - $484,343
23,615 Added 45.84%
75,127 $1.54 Million
Q2 2025

Aug 12, 2025
SELL
$7.44 - $15.44 $20,207 - $41,935
-2,716 Reduced 5.01%
51,512 $695,000
Q1 2025

Sep 15, 2025
BUY
$4.14 - $9.47 $11,244 - $25,720
2,716 Added 5.27%
54,228 $469,000
Q1 2025

May 09, 2025
BUY
$4.14 - $9.47 $52,478 - $120,041
12,676 Added 30.51%
54,228 $469,000
Q4 2024

Feb 06, 2025
SELL
$3.83 - $7.83 $26,369 - $53,909
-6,885 Reduced 14.21%
41,552 $201,000
Q2 2024

Aug 12, 2024
BUY
$8.8 - $13.17 $47,572 - $71,197
5,406 Added 12.56%
48,437 $484,000
Q1 2024

May 08, 2024
SELL
$11.47 - $16.17 $21,471 - $30,270
-1,872 Reduced 4.17%
43,031 $522,000
Q2 2023

Aug 09, 2023
SELL
$11.63 - $15.63 $69 - $93
-6 Reduced 0.01%
44,903 $641,000
Q1 2023

May 11, 2023
SELL
$12.54 - $19.38 $26,923 - $41,608
-2,147 Reduced 4.56%
44,909 $657,000
Q4 2022

Feb 13, 2023
SELL
$13.77 - $22.04 $12,365 - $19,791
-898 Reduced 1.87%
47,056 $790,000
Q3 2022

Nov 14, 2022
BUY
$13.74 - $30.13 $22,066 - $48,388
1,606 Added 3.47%
47,954 $712,000
Q2 2022

Aug 15, 2022
BUY
$21.94 - $40.49 $27,315 - $50,410
1,245 Added 2.76%
46,348 $1.27 Million
Q1 2022

May 13, 2022
BUY
$35.27 - $62.91 $36,433 - $64,986
1,033 Added 2.34%
45,103 $1.7 Million
Q4 2021

Feb 11, 2022
BUY
$53.57 - $98.0 $38,195 - $69,874
713 Added 1.64%
44,070 $2.74 Million
Q3 2021

Nov 16, 2021
BUY
$50.93 - $85.55 $153,299 - $257,505
3,010 Added 7.46%
43,357 $3.71 Million
Q2 2021

Aug 16, 2021
BUY
$42.76 - $63.33 $31,214 - $46,230
730 Added 1.84%
40,347 $2.5 Million
Q1 2021

May 17, 2021
BUY
$33.36 - $62.2 $129,003 - $240,527
3,867 Added 10.82%
39,617 $1.93 Million
Q4 2020

Feb 16, 2021
BUY
$19.04 - $33.1 $52,645 - $91,521
2,765 Added 8.38%
35,750 $1.11 Million
Q3 2020

Nov 13, 2020
SELL
$12.99 - $21.78 $13,964 - $23,413
-1,075 Reduced 3.16%
32,985 $688,000
Q2 2020

Aug 14, 2020
BUY
$8.34 - $13.69 $17,180 - $28,201
2,060 Added 6.44%
34,060 $444,000
Q3 2019

Nov 08, 2019
BUY
$13.6 - $16.96 $54,699 - $68,213
4,022 Added 14.38%
32,000 $464,000
Q2 2019

Aug 09, 2019
BUY
$10.43 - $16.62 $291,810 - $464,994
27,978 New
27,978 $454,000

Others Institutions Holding OPRX

# of Institutions
138
Shares Held
14.4M
Call Options Held
149K
Put Options Held
52.6K
View Full List

About OptimizeRx Corp

OPRX Quotes by TradingView
  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $274M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email